• Organisational Structure

    Medical Director: Prof. Thomas Lion, MD, PhD 
    Vice-Medical Director: Prof. Dr. Oskar A. Haas
    Management: Prof. Helmut Gadner, MD l Roland Lavaulx de Vrécourt, PhD
    Secretary: Brigitte Glatz

    Divison of Molecular Genetic Analysis and Molecular Microbiology
    Prof. Thomas Lion, MD, PhD l Ing. Helga Daxberger l DI Dragana Jugovic l Michaela Nesslböck l Sandra Preuner, MSc l Bettina Berkowitsch, MSc l Simone Dworzak, MSc l Susanna Koskela, MSc l Stefan Czurda, PhD 
    Division of Cytogenetics and Molecular Cytogenetics
    Gudrun Divoky l Ulrike Engel l Brigitte Grimm l Margit König l Bettina Nocker l Eva Winkler l Sven Wohlmacher l Sabrina Haslinger, MSc l Andrea Inthal, PhD
    Division of Pharmacological Analysis
    Assoc. Prof. Ulrike Kastner, MD, PhD l Ulrike Engel l Eva Winkler

  • The following CCRI working groups and staff contribute to the activities of diagnostics provided by LabDia:

    Clinical Cell Biology & FACS Core Unit Group
    Assoc. Prof. Gerhard Fritsch, PhD l 
    Christine Freimüller, MSc l René Geyeregger, PhD l 
    Ing. Dieter Printz l Julia Stemberger l Dijana Trbojevic l 
    Elke Zipperer l Nelli Frank, MSc l Daniela Scharner l
    Immunological Diagnostics Group
    Assoc. Prof. Michael Dworzak, MD l 
    Angela Schumich l Susanne Suhendra
    Biology of Leukaemias Group
    Prof. Renate E. Panzer-Grümayer, MD l 
    Susanne Fischer l Astrid Mecklenbräuker l
    Tumour Biology Group
    Assoc. Prof. Peter Ambros, PhD l 
    Ingeborg M. Ambros, MD l Bettina Brunner l Andrea Ziegler l

About the company

The SME Labdia Labordiagnostik GmbH was established in the year 2006 (with Prof. Thomas Lion, MD, PhD, as Medical Director) as a nonprofit subsidiary of the St. Anna Children’s Cancer Research Association, with the aim of promoting development and offering innovative diagnostic approaches. The main areas of our activity include haematology/oncology and infectiology. 

In close cooperation with the St. Anna Children’s Cancer Research Institute (CCRI) and other national and international research centres, we are continuously establishing and validating new assays and introducing them into clinical diagnostics. All diagnostic tests provided are based on our own developments, some of which have been patented. We actively participate in national and international boards focusing on the standardisation of different diagnostic methodologies, and have coordinated European activities in the field of diagnostic development in projects supported by the EU. Owing to the established network with other leading diagnostic centres in Europe, our regular participation in national and international control rounds, and our tight links with research and development, LabDia has access to the latest technical know-how and offers high competence in specialised diagnostic services.

In addition to our activities as a diagnostic reference centre for national and international therapeutic trials, LabDia also offers its services to individual patients treated at various centres in Austria and other countries. The most important diagnostic methodologies currently offered by LabDia include cytogenetic analyses, fluorescence in situ hybridisation (FISH) assays, qualitative and quantitative PCR tests, pharmacokinetic analyses, flow cytometry and cell sorting by FACS, as well as investigation of DNA mutations by various techniques. LabDia is an internationally certified competence centre for comprehensive diagnostics of chronic myeloid leukaemia (CML), which is an important focus within our spectrum of diagnostic activities. The current range of diagnostic tests offered by individual divisions of Labdia Labordiagnostik is displayed on our website www.labdia.at.